Congress Trades
Latest disclosures
| Chamber | Transaction Date | Member | Owner | Asset | Action | Amount | Ticker ▲ | Δ Since Trade |
|---|---|---|---|---|---|---|---|---|
| Senate | Nov. 1, 2018 | David Perdue | Joint | Pfizer Inc. | SALE (PARTIAL) | $1,001 - $15,000 | PFE | ▼ -40.56% |
| Senate | Feb. 9, 2017 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $1,001 - $15,000 | PFE | ▼ -19.81% |
| Senate | Jan. 13, 2016 | David Perdue | Joint | Pfizer Inc. | SALE (PARTIAL) | $1,001 - $15,000 | PFE | ▼ -14.52% |
| House | Oct. 21, 2024 | Laurel Lee | Spouse | Pfizer Inc | PURCHASE | $15,001 - $50,000 | PFE | ▼ -14.93% |
| Senate | Dec. 18, 2023 | Shelley Moore Capito | Spouse | Pfizer Inc | SALE (PARTIAL) | $1,001 - $15,000 | PFE | ▼ -9.05% |
| Senate | Jul. 9, 2020 | Thomas R. Carper | Spouse | Pfizer Inc. | PURCHASE | $1,001 - $15,000 | PFE | ▼ -22.41% |
| House | Mar. 25, 2024 | Ro Khanna | Pfizer Inc | PURCHASE | $1,001 - $15,000 | PFE | ▼ -10.28% | |
| Senate | Jun. 4, 2018 | Susan M. Collins | Spouse | Pfizer Inc. | SALE (FULL) | $1,001 - $15,000 | PFE | ▼ -28.77% |
| House | Apr. 8, 2025 | Rob Bresnahan | Pfizer Inc | SALE | $15,001 - $50,000 | PFE | ▲ +12.68% | |
| House | Feb. 25, 2025 | Rob Bresnahan | Pfizer Inc | PURCHASE | $15,001 - $50,000 | PFE | ▼ -7.97% | |
| House | Aug. 1, 2024 | Scott Mr Franklin | Pfizer, Inc. Common Stock | SALE (FULL) | $1,001 - $15,000 | PFE | ▼ -19.71% | |
| House | Aug. 6, 2024 | Scott Mr Franklin | Pfizer, Inc. Common Stock | SALE (FULL) | $15,001 - $50,000 | PFE | ▼ -16.06% | |
| Senate | Feb. 17, 2017 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $1,001 - $15,000 | PFE | ▼ -22.78% |
| Senate | Feb. 22, 2017 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $15,001 - $50,000 | PFE | ▼ -22.71% |
| Senate | Feb. 7, 2017 | David Perdue | Joint | Pfizer Inc. | PURCHASE | $1,001 - $15,000 | PFE | ▼ -19.07% |
| Senate | Jun. 3, 2025 | Ron Wyden | Spouse | Pfizer Inc | SALE | $1,001 - $15,000 | PFE | ▲ +5.40% |
| Senate | Jun. 3, 2025 | Ron Wyden | Spouse | Pfizer, Inc. Common Stock | SALE (FULL) | $1,001 - $15,000 | PFE | ▲ +5.40% |
| Senate | Feb. 13, 2025 | John Boozman | Joint | Pfizer Inc | SALE (FULL) | $1,001 - $15,000 | PFE | ▼ -4.02% |
| Senate | Nov. 17, 2020 | Jacklyn Rosen | Joint | Pfizer Inc. (Exchanged) <br> Viatris Inc. (Received) | EXCHANGE | $1,001 - $15,000 | PFEVTRS | — |
| House | Jun. 17, 2025 | Lisa McClain | Spouse | Principal Financial Group Inc | PURCHASE | $1,001 - $15,000 | PFG | ▲ +7.07% |
| Senate | Jan. 5, 2018 | Pat Toomey | Joint | Provident Financial Services, Inc. | SALE (PARTIAL) | $1,001 - $15,000 | PFS | ▼ -31.08% |
| Senate | Jan. 5, 2018 | Pat Toomey | Joint | Provident Financial Services, Inc. | SALE (PARTIAL) | $1,001 - $15,000 | PFS | ▼ -31.08% |
| Senate | Jan. 8, 2018 | Pat Toomey | Joint | Provident Financial Services, Inc. | SALE (FULL) | $1,001 - $15,000 | PFS | ▼ -31.06% |
| Senate | Jan. 8, 2018 | Pat Toomey | Joint | Provident Financial Services, Inc. | SALE (FULL) | $1,001 - $15,000 | PFS | ▼ -31.06% |
| Senate | May. 3, 2024 | Tommy Tuberville | Joint | Procter & Gamble Company (The) Common Stock | SALE (FULL) | $1,001 - $15,000 | PG | ▼ -11.35% |
| Senate | Jan. 19, 2024 | Tommy Tuberville | Joint | Procter & Gamble Company (The) Common Stock | PURCHASE | $1,001 - $15,000 | PG | ▼ -1.21% |
| Senate | Sep. 21, 2023 | Pete Ricketts | Spouse | The Procter & Gamble Co | SALE | $100,001 - $250,000 | PG | ▼ -4.17% |
| Senate | Jul. 24, 2023 | Tommy Tuberville | Joint | Procter & Gamble Company (The) Common Stock | SALE (FULL) | $1,001 - $15,000 | PG | ▼ -4.97% |
| Senate | May. 8, 2023 | Tommy Tuberville | Joint | Procter & Gamble Company (The) Common Stock | SALE (PARTIAL) | $1,001 - $15,000 | PG | ▼ -6.12% |
| Senate | Jan. 21, 2022 | Tommy Tuberville | Joint | Procter & Gamble Company (The) Common Stock | SALE (FULL) | $15,001 - $50,000 | PG | ▼ -10.35% |
Last updated: Nov 5, 22:39